Table 6 Expedited ethical review time frames
Expedited ethical review time frames | Outbreak | Study setting | Time frame |
|---|---|---|---|
Through an accelerated WHO ethical review process, a sub-committee established specifically for review of Ebola studies reviewed protocols in 6 days (max. 15 days) on average during the 2014–2016 outbreak. Barriers causing delays were mainly protocol related [18]. | Ebola 2014–2016 | West Africa | 6 days on average |
An H1N1 pandemic vaccine cohort study in the UK in 2009 was through expedited review processes approved by the Oxfordshire Research Ethics Committee within 18 days. Subsequent substantial amendments were approved within 48 h [53]. | H1N1 2009 | UK | 18 days |